We wish to update our investors that, as approved by the Hon’ble National Company Law Tribunal (NCLT), Hyderabad Bench, Medinova Diagnostic Services Ltd will be amalgamated with Vijaya Diagnostic Centre Ltd under an approved Scheme of Amalgamation.

Key Details:

Record Date: 25th November 2025

Effective from 25th November 2025, trading in the equity shares of Medinova Diagnostic Services Ltd will be suspended to facilitate the amalgamation process.

Share Exchange Ratio:

Shareholders of Medinova Diagnostic Services Ltd will receive: 1 fully paid-up equity share of ₹1 each in Vijaya Diagnostic Centre Ltd, for every 22 fully paid-up equity shares of ₹10 each held in Medinova Diagnostic Services Ltd.

This ensures that all eligible shareholders will be allotted shares of Vijaya Diagnostic Centre Ltd in accordance with the approved scheme.

What is an Amalgamation?

An amalgamation is a legal process where one company merges into another, combining assets, liabilities, and operations. The goal is to streamline the structure, enhance operational efficiency, reduce redundancies, and create a stronger unified entity.

Purpose of This Amalgamation

This merger aims to:

• Consolidate the operations of both healthcare entities under one corporate structure

• Improve service efficiency and operational synergy

• Strengthen the combined company’s reach and healthcare offerings

• Enhance long-term value for shareholders of both companies

Important Note:

All trading in the equity shares of Medinova Diagnostic Services Ltd will cease from 25th November 2025. Share allotment under the exchange ratio will be credited directly to the demat accounts of eligible shareholders once the amalgamation becomes effective.

Conclusion

This merger marks an important step in strengthening the overall business and service capabilities of Vijaya Diagnostic Centre Ltd. Shareholders of Medinova Diagnostic Services Ltd will automatically receive the allotted shares as per the exchange ratio, ensuring a smooth transition under the approved scheme.